In particular, KOLON Life Science has developed for the first time in the world a new medicine in the form of cell and gene treatment for degenerative
arthritis from which many people suffer in this era of aging populations. In addition, KOLON Life Science is also concentrating its research capacity in
the field of gene medicine including neuropathic pain medicine and anti-cancer drugs. KOLON Life Science will continue to promote its substantial
growth through market expansion for its fields of business, alliance with global partners and the development of new products.